← Eichor
Condition: Residual Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Residual

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Hearing Preservation in Cochlear Implantation Surgery
NA · 1 location(s) · UMC Utrecht · NCT07146841Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
Phase 2 · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06511882Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial
Phase N/A · 1 location(s) · OHSU Knight Cancer Institute · NCT07726602Discontinuation Study
NA · 1 location(s) · University College Cork · NCT05866757Cholesterol Lowering and Residual Risk in Diabetes, Type 1
Phase 4 · 4 location(s) · NYU Langone Health · NCT05641753Bright Light Therapy for OSA
NA · 1 location(s) · VA Office of Research and Development · NCT05917119Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT06840262ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06426511The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreati
NA · 1 location(s) · Peking Union Medical College Hospital · NCT05802394MRD Response-adapted Allo-HSCT for Adverse-risk AML
NA · 1 location(s) · Peking University People's Hospital · NCT06301425Creation of a Digital Twin for Predicting the Progression of Patients With Chronic Thoracic Aortic Dissection
NA · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT07315178Risk Stratification and MRD-driven Maintenance for MM After ASCT
NA · 4 location(s) · Peking University People's Hospital · NCT06697483Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
Phase 1 · 1 location(s) · University of Illinois at Chicago · NCT05192122Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07500441Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Ind
Phase N/A · 1 location(s) · Massachusetts Eye and Ear Infirmary · NCT06744296A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapa
Phase 1/Phase 2 · 2 location(s) · Johnny Ludvigsson · NCT07199946ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07270666CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Phase 3 · 1 location(s) · Peking University People's Hospital · NCT07441291Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
Phase 1 · 1 location(s) · University of Virginia · NCT07270978Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
Phase 2 · 20 location(s) · UNICANCER · NCT05973864Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke
Phase 1 · 1 location(s) · University of Texas at Austin · NCT06365099Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
Phase 2 · 1 location(s) · UNICANCER · NCT06450314Comparison of an Acceleromyography- and Electromyography-based Neuromuscular Monitor With TOF-Watch ® Monitor
Phase N/A · 2 location(s) · Huazhong University of Science and Technology · NCT05632107Tessa Jowell BRAIN MATRIX - Platform Study
Phase N/A · 14 location(s) · University of Birmingham · NCT04274283tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
Phase 3 · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT06332274Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV
NA · 1 location(s) · Xi'an No.3 Hospital · NCT06001047cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas
NA · 4 location(s) · Centre Jean Perrin · NCT07178847Residual Exacerbations With Mepolizumab
Phase N/A · 1 location(s) · Laval University · NCT04578171Mandibular Overdentures Retained by Four Locator Attachments Versus Four-Implant Bar Attachments
Phase N/A · 1 location(s) · Menoufia University · NCT07093853Long-term Outcomes After Percutaneous Patent Foramen Ovale Closure (Severance PFO Registry)
Phase N/A · 1 location(s) · Yonsei University · NCT07724171
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.